Algernon Health bets on the brain: Inside its move into Alzheimer's diagnostics

Christopher Moreau isn’t shy about his ambitions. The CEO of Algernon Health (CSE:AGN, OTCQB:AGNPF) wants to build a network of neuroimaging centers across North America, clinics that could help detect Alzheimer’s disease earlier, faster, safer, and more comfortably than ever before. The Vancouver-based company is aiming to open its first dedicated brain imaging center in the US by spring, according to its CEO. “There’s a massive need,” Moreau told Proactive. Algernon Health, a rebranded version of Algernon ...